Aspirin and the prevention of cardiovascular disease in chronic kidney disease: time to move forward?
Wali
Ravinder K
RK
D001241:Aspirin / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000401:mortality / Q000517:prevention & control*; D002908:Chronic Disease; D003404:Creatinine / Q000097:blood; D005919:Glomerular Filtration Rate; D006470:Hemorrhage / Q000453:epidemiology; D006801:Humans; D006973:Hypertension / Q000150:complications*; D007674:Kidney Diseases / Q000150:complications*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D011322:Primary Prevention; D018570:Risk Assessment
D010975:Platelet Aggregation Inhibitors; D003404:Creatinine; D001241:Aspirin